DNA hypermethylation near the transcription start site of collagen α2(I) gene occurs in both cancer cell lines and primary colorectal cancers

Cancer Research

Volumn 63, Issue 8, 2003, Pages 1789-1797

  Sengupta, Pritam K ^a,b   Smith, Erin M ^a,b   Kim, Kwonseop ^d   Murnane, Mary Jo ^a,c   Smith, Barbara D ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; COLLAGEN TYPE 2; COLLAGEN TYPE 2ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; COLORECTAL CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA METHYLATION; GENE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE; TRANSCRIPTION INITIATION SITE; TUMOR CELL LINE;

AZACITIDINE; BASE SEQUENCE; COLLAGEN TYPE I; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION INITIATION SITE; TUMOR CELLS, CULTURED;

EID: 0037447149     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Dahlman, T., Lammerts, E., Bergstrom, D., Franzen, A., Westermark, K., Heldin, N. E., and Rubin, K. Collagen type I expression in experimental anaplastic thyroid carcinoma: regulation and relevance for tumorigenicity. Int. J. Cancer, 98: 186-192, 2002.
2. Kauppila, S., Stenback, F., Risteli, J., Jukkola, A., and Risteli, L. Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J. Pathol., 186: 262-268, 1998.
3. Adams, S. L., Sobel, M. E., Howard, B. H., Olden, K., Yamada, K. M., de Crombrugghe, B., and Pastan, I. Levels of translatable mRNAs for cell surface protein, collagen precursors, and two membrane proteins are altered in Rous sarcoma virus-transformed chick embryo fibroblasts. Proc. Natl. Acad. Sci. USA, 74: 3399-3403, 1977.
4. Rowe, D. W., Moen, R. C., Davidson, J. M., Byers, P. H., Bornstein, P., and Palmiter, R. D. Correlation of procollagen mRNA levels in normal and transformed chick embryo fibroblasts with different rates of procollagen synthesis. Biochemistry, 17: 1581-1590, 1978.
5. Smith, B. D., and Niles, R. Characterization of collagen synthesized by normal and chemically transformed rat liver epithelial cell lines. Biochemistry, 19: 1820-1825, 1980.
6. Sandmeyer, S., Smith, R., Kiehn, D., and Bornstein, P. Correlation of collagen synthesis and procollagen messenger RNA levels with transformation in rat embryo fibroblasts. Cancer Res., 41: 830-838, 1981.
7. Smith, B. D., and Marsilio, E. Methylation of the alpha 2(I) collagen gene in chemically transformed rat liver epithelial cells. Biochem. J., 253: 269-273, 1988.
8. Guenette, D. K., Ritzenthaler, J. D., Foley, J., Jackson, J. D., and Smith, B. D. DNA methylation inhibits transcription of procollagen alpha 2(I) promoters. Biochem. J., 283: 699-703, 1992.
9. Sengupta, P. K., and Smith, B. D. Methylation in the initiation region of the first exon suppresses collagen pro-alpha2(I) gene transcription. Biochim. Biophys. Acta, 1443: 75-89, 1998.
10. Sengupta, P. K., Erhlich, M., and Smith, B. D. A methylation-responsive MDBP/RFX site is in the first exon of the collagen alpha 2(I) promoter. J. Biol. Chem., 274: 36649-36655, 1999.
11. Sengupta, P. K., Fargo, J., and Smith, B. D. RFX family interacts at the collagen (COL1A2) start site and represses transcription. J. Biol. Chem., 277: 24926-24937, 2002.
12. Huang, L. H., Wang, R., Gama-Sosa, M. A., Shenoy, S., and Ehrlich, M. A protein from human placental nuclei binds preferentially to 5-methylcytosine-rich DNA. Nature, 308: 293-295, 1984.
13. Reith, W., Ucla, C., Barras, E., Gaud, A., Durand, B., Herrero-Sanchez, C., Kobr, M., and Mach, B. RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol. Cell. Biol., 14: 1230-1244, 1994.
14. Emery, P., Durand, B., Mach, B., and Reith, W. RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res., 24: 803-807, 1996.
15. Zhang, X. Y., Jabrane-Ferrat, N., Asiedu, C. K., Samac, S., Peterlin, B. M., and Ehrlich, M. The major histocompatibility complex class II promoter-binding protein RFX (NF-X) is a methylated DNA-binding protein. Mol. Cell. Biol., 13: 6810-6818, 1993.
16. Zhang, X. Y., Asiedu, C. K., Supakar, P. C., Khan, R., Ehrlich, K. C., and Ehrlich, M. Binding sites in mammalian genes and viral gene regulatory regions recognized by methylated DNA-binding protein. Nucleic Acids Res., 18: 6253-6260, 1990.
17. Bird, A. P., and Wolffe, A. P. Methylation-induced repression: belts, braces, and chromatin. Cell, 99: 451-454, 1999.
18. Chan, M. F., Liang, G., and Jones, P. A. Relationship between transcription and DNA methylation. Curr. Top. Microbiol. Immunol., 249: 75-86, 2000.
19. Jones, P. A., and Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3: 415-428, 2002.
20. Baylin, S. B., Esteller, M., Rountree, M. R., Bachman, K. E., Schuebel, K., and Herman, J. G. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet., 10: 687-692, 2001.
21. Kim, K., Cai, J., Shuja, S., Kuo, T., and Murnane, M. J. Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas. Int. J. Cancer, 79: 324-333, 1998.
22. Kim, K., Kuo, T., Cai, J., Shuja, S., and Murnane, M. J. N-ras protein: frequent quantitative and qualitative changes occur in human colorectal carcinomas. Int. J. Cancer, 71: 767-775, 1997.
23. Iacobuzio-Donahue, C., Cai, J., Nogueira, C., Shuja, S., Kim, K., and Murnane, M. J. Correlation of increased cathepsin B expression with p53 loss of heterozygosity at the transition from colorectal adenoma to carcinoma. Proc. Am. Assoc. Cancer Res., 37: 95, 1996.
24. Clark, S. J., Harrison, J., Paul, C. L., and Frommer, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22: 2990-2997, 1994.
25. Gonzalgo, M. L., and Jones, P. A. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res., 25: 2529-2531, 1997.
26. Winer, J., Jung, C. K., Shackel, I., and Williams, P. M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem., 270: 41-49, 1999.
27. Gibson, U. E., Heid, C. A., and Williams, P. M. A novel method for real time quantitative RT-PCR. Genome Res., 6: 995-1001, 1996.
28. Heid, C. A., Stevens, J., Livak, K. J., and Williams, P. M. Real time quantitative PCR. Genome Res., 6: 986-994, 1996.
29. Livak, K. J., and Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25: 402-408, 2001.
30. Katan, Y., Agami, R., and Shaul, Y. The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities. Nucleic Acids Res., 25: 3621-3628, 1997.
31. Katan-Khaykovich, Y., Spiegel, I., and Shaul, Y. The dimerization/repression domain of RFX1 is related to a conserved region of its yeast homologues Crt1 and Sak1: a new function for an ancient motif. J. Mol. Biol., 294: 121-137, 1999.
32. Tait, L., Soule, H. D., and Russo, J. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50: 6087-6094, 1990.
33. Soule, H. D., Maloney, T. M., Wolman, S. R., Peterson, W. D., Jr., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50: 6075-6086, 1990.
34. Schroy, P. C., III, Brown-Shimer, S., Kim, K., Johnson, K. A., Murnane, M. J., Yang, S., O'Brien, M. J., Carney, W. P., and Kupchik, H. Z. Detection of p21ras mutations in colorectal adenomas and carcinomas by enzyme-linked immunosorbent assay. Cancer, 76: 201-209, 1995.
35. Shuja, S., Sheahan, K., and Murnane, M. J. Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Int. J. Cancer, 49: 341-346, 1991.
36. Murnane, M. J., Sheahan, K., Ozdemirli, M., and Shuja, S. Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res., 51: 1137-1142, 1991.
37. del Re, E. C., Shuja, S., Cai, J., and Murnane, M. J. Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas. Br. J. Cancer, 82: 1317-1326, 2000.
38. Iacobuzio-Donahue, C. A., Shuja, S., Cai, J., Peng, P., and Murnane, M. J. Elevations in cathepsin B protein content and enzyme activity occur independently of glycosylation during colorectal tumor progression. J. Biol. Chem., 272: 29190-29199, 1997.
39. Plass, C., and Soloway, P. D. DNA methylation, imprinting and cancer. Eur. J. Hum. Genet., 10: 6-16, 2002.
40. Baylin, S., and Bestor, T. H. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell, 1: 299-305, 2002.
41. Parker, M. I., Judge, K., and Gevers, W. Loss of type I procollagen gene expression in SV40-transforrned human fibroblasts is accompanied by hypermethylation of these genes. Nucleic Acids Res., 10: 5879-5891, 1982.
42. Wang, R. Y., Zhang, X. Y., and Ehrlich, M. A human DNA-binding protein is methylation-specific and sequence-specific. Nucleic Acids Res., 14: 1599-1614, 1986.
43. Prokhortchouk, A., Hendrich, B., Jorgensen, H., Ruzov, A., Wilm, M., Georgiev, G., Bird, A., and Prokhortchouk, E. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev., 15: 1613-1618, 2001.
44. Kim, S. W., Fang, X., Ji, H., Paulson, A. F., Daniel, J. M., Ciesiolka, M., van Roy, F., and McCrea, P. D. Isolation and characterization of XKaiso, a transcriptional repressor that associates with the catenin Xp120(ctn) in Xenopus laevis. J. Biol. Chem., 277: 8202-8208, 2002.
45. Daniel, J. M., Spring, C. M., Crawford, H. C., Reynolds, A. B., and Baig, A. The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res., 30: 2911-2919, 2002.
46. Aoki, K., Meng, G., Suzuki, K., Takashi, T., Kameoka, Y., Nakahara, K., Ishida, R., and Kasai, M. RP58 associates with condensed chromatin and mediates a sequence-specific transcriptional repression. J. Biol. Chem., 273: 26698-26704, 1998.
47. Fuks, F., Burgers, W. A., Godin, N., Kasai, M., and Kouzarides, T. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J., 20: 2536-2544, 2001.
48. Wolffe, A. P. Chromatin remodeling regulated by steroid and nuclear receptors. Cell Res., 7: 127-142, 1997.
49. Wei, L. N. Retinoid receptors and their coregulators. Annu. Rev. Pharmacol. Toxicol., 43: 47-72, 2003.
50. Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., and Wolffe, A. P. DNMTI forms a complex with Rb. E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet., 25: 338-342, 2000.
51. Ferreira, R., Naguibneva, I., Pritchard, L. L., Ait-Si-Ali, S., and Harel-Bellan, A. The Rb/chromatin connection and epigenetic control: opinion. Oncogene, 20: 3128-3133, 2001.
52. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev., 16: 6-21, 2002.
53. Ballestar, E., and Esteller, M. The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis, 23: 1103-1109, 2002.
54. Hassan, A. H., Neely, K. E., Vignali, M., Reese, J. C., and Workman, J. L. Promoter targeting of chromatin-modifying complexes. Front. Biosci., 6: D1054-D1064, 2001.
55. Bell, A. C., and Felsenfeld, G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature, 405: 482-485, 2000.
56. Prendergast, G. C., and Ziff, E. B. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science, 251: 186-189, 1991.
57. Geddis, A. E., and Prockop, D. J. Expression of human COL1A1 gene in stably transfected HT1080 cells: the production of a thermostable homotrimer of type I collagen in a recombinant system. Matrix, 13: 399-405, 1993.
58. Fertala, A., Sieron, A. L., Ganguly, A., Li, S. W., Ala-Kokko, L., Anumula, K. R., and Prockop, D. J. Synthesis of recombinant human procollagen II in a stably transfected tumour cell line (HT1080). Biochem. J., 298: 31-37, 1994.
59. Christman, J. K. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene, 21: 5483-5495, 2002.
60. Juttermann, R., Li, E., and Jaenisch, R. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc. Natl. Acad. Sci. USA, 91: 11797-11801, 1994.
61. Ahuja, N., Mohan, A. L., Li, Q., Stolker, J. M., Herman, J. G., Hamilton, S. R., Baylin, S. B., and Issa, J. P. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res., 57: 3370-3374, 1997.
62. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., and Issa, J. P. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA, 96: 8681-8686, 1999.
63. Vogelstein, B., and Kinzler, K. W. Colorectal cancer and the intersection between basic and clinical research. Cold Spring Harb. Symp. Quant. Biol., 59: 517-521, 1994.
64. Toyota, M., Ohe-Toyota, M., Ahuja, N., and Issa, J. P. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc. Natl. Acad. Sci. USA, 97: 710-715, 2000.
65. Smith, B. D., Mahoney, A. P., and Feldman, R. S. Inverse correlation of collagen production to anchorage independence and tumorigenicity in W8- and M-cell lines. Cancer Res., 43: 4275-4282, 1983.
66. Lim, A., Greenspan, D. S., and Smith, B. D. Expression of alpha 2 type I collagen in W8 cells increases cell adhesion and decreases colony formation in soft agar. Matrix Biol., 14: 21-30, 1994.
67. Travers, H., French, N. S., and Norton, J. D. Suppression of tumorigenicity in Ras-transformed fibroblasts by alpha 2(I) collagen. Cell Growth Differ., 7: 1353-1360, 1996.